Allogenica
PrivateLast Round
Grant
Mar 19, 2025
Total Funding Raised
$3.22M
Company Overview
Allogenica operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in March 2025.
Allogenica is a biotechnology company developing universal allogeneic CAR-T cell therapies for the treatment of blood cancers, rare diseases, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allogenica Comparables
Compare Allogenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immugenia Inc. | 83% | |
| Roche Holding | 78% | |
| Allotera Therapeutics | 78% |
For institutional investors. Book with your work email.
Allogenica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 19, 2025 | ||||
| Seed | May 20, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Allogenica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Health Angels Rhône-Alpes | Seed |
| Pulsalys | Seed |
| Aloe Private Equity | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$2.7M grant received from France 2030.
- May 20, 2022
$500K round with participation from Aloe Private Equity and Health Angels.
For institutional investors. Book with your work email.
Allogenica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allogenica's valuation, stock price, and market status.
Is Allogenica a public or private company?
Allogenica is a private company.
What is the current stock price of Allogenica?
Allogenica is a private company, so its shares have no public market price. Caplight tracks Allogenica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allogenica worth (valuation)?
Valuation information for Allogenica is not publicly available.
Can I buy Allogenica stock?
Allogenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allogenica's last funding round?
Allogenica's most recent funding round was Grant on March 19, 2025.
Who are the main investors in Allogenica?
Key investors in Allogenica include France 2030, Health Angels Rhône-Alpes, Pulsalys, Aloe Private Equity.
Will Allogenica IPO soon?
No public IPO plans have been announced for Allogenica.
How can I track Allogenica secondary market activity?
Caplight tracks bids, offers, and trades in Allogenica's shares on secondary markets.